Skip to main content
Clinical Trials/IRCT2015042521937N1
IRCT2015042521937N1
Completed
Phase 2

Comparison of Traditional Medicine product and metformin and Traditional Medicine product with metformin on menstrual bleeding events in patients with polycystic ovary syndrome complaint oligomenorrhea

School of Traditional Medicine and Materia Medica Research Center Shahid Beheshti0 sites120 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Polycystic ovarian syndrome.
Sponsor
School of Traditional Medicine and Materia Medica Research Center Shahid Beheshti
Enrollment
120
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
School of Traditional Medicine and Materia Medica Research Center Shahid Beheshti

Eligibility Criteria

Inclusion Criteria

  • Patients with  PCOS their main complaint is oligomenorrhea. Age 40\-18 years, patient satisfaction, the absence of any systemic disease such as hyperinsulinemia, hyperandrogenism, diabetes mellitus, Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia and hyperthyroidism, hypertension, lack of pregnancy or within 6 weeks post\-partum, lack of breastfeeding, non\-hormonal drugs in the last month, no family history of breast and ovarian cancer. Exclusion criteria: Hormone therapy use, side effects, the need for other interventions and surgery, pregnancy occurred during the study, the patient's own request for exclusion.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials